Outcome of the Board Meeting for Re-appointment of Internal and Cost Auditor.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Privi Speciality Chemicals reported audited FY2026 results with standalone revenue of Rs. 2,45,553.47 lakhs, up 20.5% from Rs. 2,03,834.26 lakhs in FY2025. Net profit grew to Rs. 14,710.31 lakhs from Rs. 12,175.77 lakhs, an increase of about 21%. The statutory auditor BSR & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated results. The Board recommended a final dividend of Rs. 10 per share (100% on Rs. 10 face value) totaling Rs. 3,906.27 lakhs, subject to shareholder approval at the 41st AGM on August 7, 2026. The Board also re-appointed Executive Director Mr. Bhaktavatsala Rao Doppalapudi for 3 years, and retained M/s. Aneja Associates as Internal Auditor and M/s. Kishore Bhatia & Associates as Cost Auditor for FY2026-27.
Strong financial performance with double-digit revenue and profit growth signals operational strength. The clean audit opinion and consistent dividend policy are positive for investor confidence.